Objective: To scrutinize repeatability of measurements of galvanic skin response (GSR) using a complementary therapy device.
INTRODUCTION
The device scrutinized in this study (a "biophoton therapy device") claims to be a non invasive diagnostic and therapeutic tool [1] .
DIAGNOSIS
Galvanic skin response (GRS) diagnosis before therapy, as it is used here, does not necessarily follow the lines of western physiology. In contrast, it is closely related to the Asian (Chinese) system of acupuncture meridians and acupuncture points [2] . These acupuncture points are *Address correspondence to this author at the Interuniversity College for Health and Development, Graz / Castle of Seggau, Austria; Tel: 0043 316 42 38 13; E-mail: college@inter-uni.net assumed to show increased electrical conductivity [1, [3] [4] [5] , that is super influenced by the (stressed or weak) state of related organs and organ systems including the vagal / simpatico system [3] . Presumably Richard Croon was the first to discover the different electrical resistance values of the acupuncture points and developed the so-called Electro Neural Diagnosis [3] . In the 1960's, the technique was widely disseminated in Europe by Reinhard Voll and further developed as Electro Acupuncture by Voll [4] . Also in Japan early Electro Acupuncture methods originated (Yoshio Nakatani and Hiroshi Motoyama) [3] . This form of diagnosis is said to be particularly suitable in the case of chronic illness, the assumption being that it is capable of detecting hidden inflammations and toxins / environmental poisons within organ systems which are considered the source of illnesses [3, 5] .
GALVANIC SKIN RESPONSE
The Galvanic Skin Response (GSR) is one of several electro dermal responses. Electro dermal responses are changes in the electrical properties of a person's skin caused by an interaction between environmental events and the individuals' physical and psychological state. Human skin is a good conductor of electricity even if a weak electrical current is applied. Galvanic Skin Response techniques apply a constant voltage. The circuit normally includes a brass electrode to be hold in one hand or a plate to put the hand or bare foot on, and a style electrode. The current that flows through the skin, as the voltage is applied, can be detected and displayed [6] . When the organism is exposed to internal or external influences, this conductivity may be chronically prominent in comparison to normal, or it may change within split seconds. Chronical prominence of skin conductivity under exposure to a standard low Voltage current is the basis of clinical biophoton diagnosis. Changes within seconds or split seconds are the basis of testing materials, chemicals or information "becoming" or "unbecoming" to the tested person. In general, a "becoming" (harmonizing) information (e.g. a nutrient or a remedy) is said to lead to an increase of skin conductivity, expressed by an indicator climb, neutre information to no change and "unbecoming" (disharmonic) information to a decrease of skin conductivity, expressed by an indicator drop. By using a special low pressure measuring technique, the style electrode of the biophoton therapy device used in the studies reviewed here is reported to be distinct from older measuring electrodes and minimizes the influence of the tester and the type of skin tested [8] . It may be interesting to note that the scale showing the decrease in skin conductivity is broader in the device used here than in devices of Electro Acupuncture according to Voll.
INFORMATION TRANSFER
When the influence of becoming or unbecoming information is tested (on clients in order to find a therapeutic decision or on volunteers in the course of an experiment), the probe may be swallowed, or put directly on the bare skin, or it may be sealed in a (quartz) glass vial that is put on the skin or a mucous membrane [7] . Furthermore, the test probe may (directly or contained in a glass vial) be placed in a brass beaker (cup) that is connected to the diagnosis/therapy device. Connection may be via a closed circuit or involve one individual wire only. In the case of the biophotone therapy device scrutinized here, the individual single connection is a glass fibre cable. According to the manufacturer, glass fibre was chosen with regard to the photon nature of the information transfer. Various frequency passes may be applied, from "all pass" via " >10000 Hz", " >5000 Hz", ">2000 etc. to ">100 Hz".
TREATMENT
Treatment is based on the assumption that every biochemical reaction in organisms is preceded by electromagnetic signals, among others in the visible (VIS) or "biophoton" range, and that such photon patterns may be scanned by the device, containing one-way fibre glass cables, filters, amplifiers and elements for phase correction, and may be fed (back) to the biological system [1, 8] . Analogously, it is assumed that information from chemicals etc. may be transferred via the device.
In order to investigate possible effects of treatment with the biophoton device, pilot studies were performed previously, with promising results [9] [10] [11] .
RESEARCH QUESTIONS
Based on the abovementioned assumptions, it should be possible to measure the influence of a "becoming" (harmonizing) and an "unbecoming" (disharmonizing) probe on GSR, skin conductivity. This study is organized in tree subsequent blind experiments, with three step by step research questions.
("1V-1R"):
Is there a repeatedly measurable impact of a specific probe, tested versus control, on one volunteer's GSR, diagnosed by one single tester?
("5V-1R"):
Is there a repeatedly measurable impact of the specific probe, tested versus control, on several volunteers' GSR, diagnosed by one single tester?
("5V-5R"):
Is there a repeatedly measurable impact of the specific probe, tested versus control, on several volunteers' GSR, diagnosed by several testers?
METHODS

Test Probe and Device
The study design requires a substance that, in Galvanic Skin Response (GSR) measurement, is known to lead to a decrease of GSR. Here, the drug Paracetamol® (N-acetyl-paminophenol. N-acetyl-p-aminophenol) was used. Both in animals and in humans the substance has an analgesic and fever-reducing effect [12, 13] . This pharmacological effect is probably caused by inhibition of an enzyme hormone synthesizing system (prostaglandin synthetase) in the brain (hypothalamus). In spite of its obvious beneficial effects in everyday clinical and over the counter healthcare, side effects [14, 15] and mild overdose effects were reported [16, 17] and adherents of "holistic" approaches in medicine argued that Paracetamol ® on the long run use and abuse reduces the capacity of the organism for self regulation and self healing (personal communication). This led to preliminary experiments on information transfer from that substance via the "Biophoton Therapy Device" showing a decrease in GSR at the acupuncture point "TW-1D-lefthandpituitary gland" (unpublished material). Thus here, Paracetamol ® is considered as an agent that, although useful in conventional medicine, uses to lead to a decrease in GSR. 500 mg Paracetamol ® were dissolved in 1 ml noncarbonated mineral water (test probe), and 1 ml noncarbonated mineral water was used as the control probe. At all times, a minimum distance of 80 cm was maintained between the containers. Both test and control probe were put into separate quartz glass vials.
Following a sequence unknown to the tester, the vials with test and control probes were inserted into the "input" quartz-glass beaker of the "Biophoton Therapy Device J. Boswinkel" (Health Angel International AS, type Chiren 4746, Germany).
Measurement Point, Timing, Observed Parameter
Changes in GSR due to Paracetamol ® are assumed to be measurable at the acupuncture point "TW-1D-lefthandpituitary gland" (Fig. 1) . One measurement was given 30 sec, and GSR values were expected to recover within 5 min after application of the test probe.
A brass electrode moistened with water was held in the volunteer's right hand. This hand electrode was connected to the device by an electric cable. The tester, a trained biophoton therapist (i.e. with a minimum of 3 years training which, in the Netherlands, is equivalent to a Bachelor's level), tipped the pin of the measuring style electrode onto the abovementioned acupuncture point. According to the manufacturer, this style electrode is specially designed to balance variations in pressure applied by the tester. The observed parameter was the decrease of GSR, expressed by an indicator drop on the analogue display of the device (arbitrary units) combined with an acoustic signal.
An additional person (assistant) observed / listened to the results and noted them into the protocol.
Design and Participants
All volunteers were treated with the standard "harmonizing" programme of the therapy device before the onset of the measurements. During the experiment, following a first ("warming up") measurement, the assistant put the test or control probe in the input beaker which is connected to the biophoton therapy device by a glass fibre cable. This was given 30 seconds. Then, the second measurement was performed, this was given 2 sec. Following, there was a 5 minutes break to let reset the original basic value of GSR at the acupuncture point. This was repeated for a total of 5 applications of test or control probe, 5 breaks and 11 measurements per sequence. Each part of the study consisted of 5 unblinded pilot sequences and 10 blinded main sequences. In the study design 2 ("5V-1R") the volunteers were rotating during the measurements and in the study design 3 ("5V-5R") both volunteers and testers were rotating. The studies took part in therapist's rooms in Ter Aar and Haarlem, The Netherlands. Volunteers (2 male, 3 female) were between 32 and 65 years old; testers (1 male, 4 female, JM, RS and FA, see list of authors) were between 30 and 56 years old. All volunteers and testers were in good subjective health. Table 1 shows the protocol of one sequence of the unblinded pilot phase. 11 measurements were involved, with 5 applications of the test probe and five breaks for recovery of GSR values. One volunteer, one tester and one assistant were involved, and the sequence was applied to the volunteer 5 times subsequently. Table 2 shows the protocol of one sequence of the blinded main phase. 11 measurements were involved, with 5 applications of the test or control probe and five breaks for recovery of GSR values. One volunteer, one tester and one assistant were involved, and the protocol was applied to the volunteer 10 times subsequently. Table 2 . Table 1 1. Main Phase
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Pituitary Gland
Acupuncturepoint TW-1D-Lefthand
("5V-1R"):
The protocols for the sequences of the pilot and the main phase are identical with those shown in Tables 1  and 2 . Five volunteers, one tester and one assistant were involved, and the protocol was applied to each of the 5 volunteers once in the pilot phase and twice in the main phase.
("5V-5R"):
The protocols for the sequences of the pilot and the main phase are identical with those shown in Tables 1 and 2 . Five volunteers, 5 testers and one assistant were involved, and the protocol was applied to each of the 5 pairs of volunteers + testers once in the pilot phase and twice in the main phase.
The study design was approved by the ethics committee of the Interuniversity College.
Statistical Analysis of Data
The protocol forms were analyzed blind by the statistical department of the Interuniversity College Graz, Austria, using a two-way analysis of variance (IBM SPSS Statistics 20) . Comparisons of the frequency of diagnosed indicator "drops" was performed both between the two treatment groups and across the three sub studies. Drops were encoded as "1" and non drops as "0", and means and standard deviations were calculated. Furthermore, frequencies of diagnosed drops / non drops were compared in four field tables using Pearson's chi-square tests (IBM SPSS Statistics 20) both for the test and the control probe. These frequencies were also expressed in % of real applications of test or control substance. Table 3 compares the means and standard deviations of frequencies of diagnosed drops in the control and the test probe.
RESULTS
The means for the test probe were significantly higher than those for the control probe, both overall and for each sub study. No significant interaction was found between the variables treatment and sub study (p=.654). Eta 2 amounted to 0.199 for the overall comparison between groups. There were no differences between sub studies, regardless of whether treatments were considered together (p=.501) or separately (p=.581 for test probe, p=.581 for control probe). Eta 2 amounted to 0.010 for the overall comparison between the sub studies.
Frequencies of diagnoses were also expressed in % of real applications of control and of test substances ( Table 4) . In a random distribution, one would expect about 50% in each of the four fields. As can be seen, 73% of control applications led to "no drop" diagnoses, whereas 70% of test probe applications led to "drop" diagnoses. In other words, when one volunteer and one tester were involved, the disharmonizing test probe was correctly detected in 70% of the cases, with 30% false positive results. In reverse, the neutre control was correctly diagnosed in 73%, with 26.7 false negative results.
When 5 volunteers and one tester were involved (Table  5) , the disharmonizing test probe was correctly dedected in 70% of the cases, with 30% false positive results. In reverse, the neutre control was correctly diagnosed in 83.3%, with 16.7 false negative results.
When non drops were coded "0" and drops "1", mean + S.D. was 0.30 + 0.47 for control and 0.83 + 0.38 for the test probe.
When 5 volunteers and 5 testers were involved (Table 6) , the disharmonizing test probe was correctly dedected in 76.7% of the cases, with 23.3% false positive results. In reverse, the neutre control was correctly diagnosed in 60%, When non drops were coded "0" and drops "1", mean + S.D. was 0.40 + 0.50 for control and 0.77 + 0.43 for the test probe.
When the results of all studies 1.-3. were pooled ( Table 7 and Fig. 2) , the disharmonizing test probe was correctly detected in 77.5% of the cases, with 22.5% false positive results. In reverse, the neutre control was correctly diagnosed in 68.6%, with 31.4% false negative results. Findings are statistically significant (p < 0.01).
When non drops were coded "0" and drops "1", mean + S.D. was 0.31 + 0.47 for control and 0.78 + 0.42 for the test probe.
DISCUSSION
The objective of the study was to scrutinize repeatability of measurements of galvanic skin response (GSR) using a "biophoton device".
When one volunteer and one tester were involved, information from a "disharmonizing" test probe was correctly detected in 70% of the cases, with 30% false positive results. In reverse, control was correctly diagnosed in 73%, with 26.7 false negative results. Findings are statistically significant (p < 0.01). When 5 volunteers and one tester were involved, the test probe was correctly detected in 70% of the cases and control in 83.3% (p < 0.01). When 5 volunteers and 5 testers were involved, the test probe was correctly dedected in 76.7% and control in 60% (p < 0.05). When the results of all 3 studies were pooled, the test probe was correctly detected in 77.5% of the cases, with 22.5% false positive results. In reverse, the neutre control was correctly diagnosed in 68.6%, with 31.4% false negative results (p < 0.01).
While this paper was in preparation for print, a repetition of study 2 (above) involving one tester and 23 volunteers was performed by GF and DS at the School for Natural Medicines in Zurich, Switzerland (unpublished material). Their experimental setup was in principle the same as reported here, especially regarding the use of a biophoton therapy device, Paracetamol ® and acupuncture point "TW-1D-lefthand-pituitary gland". However, there were also methodological differences: participants were not treated with the standard "harmonizing" programme before the start of measurements; the number of measurements per participant was higher (10 instead of 5); all participants were present at the same time (albeit with those recovering or waiting between measurements in a separate room), as opposed to study 2, where participants entered the area at different times; and they had to move physically and wash their hands between sets of measurements. Furthermore, the repeat study involved more test substances and one more measuring point than study 2, (where only one test substance was tested against control and one point was measured for GRS).
In the repeat study ( Table 8 , Fig. 3) , the disharmonizing test probe (Paracetamol ® ) was correctly detected in 39.1% of cases, leaving 60.9% false positive results. In the reverse experiment, the neutre control was correctly diagnosed in 72.6%, with 27.4% false negative results. Although the differences were less marked than in the studies 1-3, they were still statistically significant (p < 0.01).
When non drops were coded "0" and drops "1", mean + S.D. was 0.27 + 0.45 for control and 0.39 + 0.49 for the test probe.
The results seem to confirm that information from biophoton therapy devices can influence biological systems and that measurements of electric skin conductivity as they are used for diagnostic purposes are repeatable under double blind conditions. Further research on the model presented here is ongoing using different test substances. Further studies may investigate the influence of the methodological differences between the original and the repeat study described above. Furthermore, independent methods (such as heart rate variability) should be used to monitor effects of information transferred via the biophoton device in order to further validate the use of skin conductivity measurements as a diagnostic tool.
Results are in line with a study performed in the 1980ies [7, 18] , using the medicine test according to Voll. A phial containing a homeopathic remedy was either placed in close proximity to a patient, or was included in a testing circuit. Electric conductivity of the skin and its changes were measured. The authors, R. van Wijk and F.A.C. Wiegant, wrote: "In both cases, the remedy is not in direct contact with the skin and the phial seems to be permeable to the 'information' which characterizes the remedy. Different series of experiments showed a significant deviation between an agitated dilution of sulphur and placebo" [18, p. 81] .
Information transfer from a drug sealed in a glass vial via an electronic circuit was also described in immunological [19, 20] and zoological experiments [21, 22] . Recent [23] .
CONCLUSION
Results suggest that information from substances can influence biological systems and that measurements of electric skin conductivity, as used for diagnostic purposes, are repeatable under standardized and blind conditions.
DISCLOSURE STATEMENT
No competing financial interests exist.
